0001214659-20-002729.txt : 20200318
0001214659-20-002729.hdr.sgml : 20200318
20200318163021
ACCESSION NUMBER: 0001214659-20-002729
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200316
FILED AS OF DATE: 20200318
DATE AS OF CHANGE: 20200318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McAvoy David R.
CENTRAL INDEX KEY: 0001758842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21088
FILM NUMBER: 20724932
MAIL ADDRESS:
STREET 1: C/O ENDOCYTE, INC., 3000 KENT AVENUE
STREET 2: SUITE A1-100
CITY: WEST LAFAYETTE
STATE: IN
ZIP: 47906
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Brickell Biotech, Inc.
CENTRAL INDEX KEY: 0000819050
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 930948554
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (720) 505-4755
MAIL ADDRESS:
STREET 1: 5777 CENTRAL AVENUE
STREET 2: SUITE 102
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: VICAL INC
DATE OF NAME CHANGE: 19940211
4
1
marketforms-48377.xml
PRIMARY DOCUMENT
X0306
4
2020-03-16
0000819050
Brickell Biotech, Inc.
BBI
0001758842
McAvoy David R.
C/O BRICKELL BIOTECH, INC.
5777 CENTRAL AVENUE, SUITE 102
BOULDER
CO
80301
false
true
false
false
General Counsel and CCO
Common Stock
28922
D
Warrants
10.36
2019-08-30
2029-08-30
Common Stock
13266
13266
D
Stock Options
4.76
2019-08-30
2029-08-30
Common Stock
90380
90380
D
Restricted Stock Units
1.54
2020-03-16
4
A
false
25000
1.54
A
2021-03-16
2030-03-15
Common Stock
25000
25000
D
/s/ David R. McAvoy
2020-03-18